Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02943317 |
Title | Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer |
Recruitment | Terminated |
Gender | female |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Verastem, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |